CCND1 and breast cancer: In addition, they evaluated its target genes (VEGF and cyclin D1), demonstrating that miR-373 acts as an oncomir, and it would be a fundamental biomarker for BC diagnosis and prognosis by VEGF and cyclin D1 targeting [60].